Answer
Myalepta (metreleptin), alongside diet, replaces leptin to treat leptin-deficiency complications in adults and children with confirmed congenital or acquired generalised lipodystrophy aged ≥2 years, or confirmed familial or acquired partial lipodystrophy aged ≥12 years when standard treatments have not achieved adequate metabolic control.
Sources for this answer
- Myalepta 3mg powder for solution for injectionChiesi Limited · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked